Hood River Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-53,483
| Closed | -$8.28M | – | 156 |
|
|
2021
Q2 | $8.28M | Sell |
53,483
-3,097
| -5% | -$479K | 0.25% | 88 |
|
|
2021
Q1 | $8.93M | Sell |
56,580
-5,537
| -9% | -$874K | 0.29% | 94 |
|
|
2020
Q4 | $14.4M | Buy |
62,117
+1,066
| +2% | +$248K | 0.48% | 81 |
|
|
2020
Q3 | $13.4M | Sell |
61,051
-6,107
| -9% | -$1.34M | 0.58% | 68 |
|
|
2020
Q2 | $19.1M | Buy |
67,158
+7,939
| +13% | +$2.26M | 0.86% | 47 |
|
|
2020
Q1 | $17.1M | Buy |
59,219
+11,459
| +24% | +$3.3M | 0.98% | 41 |
|
|
2019
Q4 | $13.7M | Buy |
47,760
+4,357
| +10% | +$1.25M | 0.59% | 72 |
|
|
2019
Q3 | $6.26M | Buy |
+43,403
| New | +$6.26M | 0.32% | 85 |
|